Christoph Rageth

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

Christoph Rageth, Elizabeth O’Flynn, Christopher Comstock et al. · Breast Cancer Research and Treatment · 2016 · 264 citations · Full text

Medicine, Pathology, Surgery +15

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

Medicine, Gynecology, Oncology +13

Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi-institutional European database

Carlos A. Garcia‐Etienne, Mariano Tomatis, Joerg Heil et al. · European Journal of Cancer · 2012 · 113 citations

Medicine, Oncology, Surgery +10

MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniques

Thomas Imschweiler, H. Haueisen, G Kampmann et al. · European Radiology · 2013 · 86 citations · Full text

Medicine, Surgery, Diagnostic Imaging +10